Boston Scientific (BSX) Equity Average (2016 - 2025)
Historic Equity Average for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $24.1 billion.
- Boston Scientific's Equity Average rose 1197.19% to $24.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $24.1 billion, marking a year-over-year increase of 1197.19%. This contributed to the annual value of $23.2 billion for FY2025, which is 1189.9% up from last year.
- Boston Scientific's Equity Average amounted to $24.1 billion in Q4 2025, which was up 1197.19% from $23.1 billion recorded in Q3 2025.
- In the past 5 years, Boston Scientific's Equity Average ranged from a high of $24.1 billion in Q4 2025 and a low of $15.5 billion during Q1 2021
- For the 5-year period, Boston Scientific's Equity Average averaged around $19.1 billion, with its median value being $18.6 billion (2023).
- In the last 5 years, Boston Scientific's Equity Average crashed by 1484.17% in 2021 and then surged by 1197.19% in 2025.
- Over the past 5 years, Boston Scientific's Equity Average (Quarter) stood at $16.5 billion in 2021, then rose by 6.44% to $17.6 billion in 2022, then rose by 9.79% to $19.3 billion in 2023, then grew by 11.12% to $21.5 billion in 2024, then increased by 11.97% to $24.1 billion in 2025.
- Its Equity Average stands at $24.1 billion for Q4 2025, versus $23.1 billion for Q3 2025 and $22.5 billion for Q2 2025.